MedTrace Logo

Online Cognitive Behavioral Intervention Program for Hong Kong People With Social Anxiety Disorder

NCT04995913 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2023-09-22

No results posted yet for this study

Summary

This study developed an online counseling program called "EASE Online" for Hong Kong people with social anxiety disorder. The program effectiveness was evaluated by a randomized controlled trial in reducing social anxiety and improving quality of life of the participants. The 3- and 6-month maintenance effects were also tested.

Conditions

Interventions

OTHER

Online cognitive behavioral therapy

The intervention includes 9 online modules, 3 face-to-face/online/telephone counseling sessions, and 2 sessions of virtual reality exposure therapy. Participants will learn and practice a variety of the cognitive behavioral skills to cope with their social anxiety. The functions of the EASE Online Program include animation briefing and debriefing, case demonstration videos, assignment and feedback, forum, internal messaging, reminder, online assessment, online booking and progress checking. The duration of the intervention is 14 weeks.

Sponsors & Collaborators

  • Research Grants Council, Hong Kong

    collaborator OTHER

  • Stockholm University

    collaborator OTHER

  • Richmond Fellowship Hong Kong

    collaborator UNKNOWN

  • Caritas Wellness Link - Tsuen Was

    collaborator UNKNOWN

  • Hong Kong Baptist University

    lead OTHER

Principal Investigators

  • Jiayan Pan, PhD · Hong Kong Baptist University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2024-03-30
Completion
2024-03-30

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04995913 on ClinicalTrials.gov